GSK says respiratory vaccine candidate accepted for review in Japan
(Alliance News) - GSK PLC on Friday said that a new drug application for its respiratory syncytial virus vaccine candidate has been accepted for review by the Japanese Ministry of Health, Labour & Welfare. Read More